Global Mydriatic Eyedrops Market Report (2025–2036)
Market Overview
The Mydriatic Eyedrops market was valued at USD xxxx million in 2025 and is projected to reach USD xxxx million by 2036, growing at a CAGR of xx% globally. Rising prevalence of eye disorders, increasing demand for diagnostic procedures such as fundoscopy, and growing use in ophthalmic surgeries are driving market growth. Technological advancements in drug formulations and expanding applications in pediatric and adult ophthalmology further support expansion.
Impact of COVID-19
The COVID-19 pandemic disrupted ophthalmic services in 2020, reducing elective eye procedures and routine diagnostics. However, recovery has been strong since 2021, supported by increased demand for ophthalmic care, rising awareness of eye health, and improved access to eye clinics and hospitals.
Market Segmentation
By Type
· Atropine Eyedrops
· Homatropine Eyedrops
· Tropicamide Eyedrops
· Cyclopentolate Eyedrops
· Dolly Eyedrops
· Others (combination formulations, customized solutions)
By Application
· Adults
· Children
· Geriatric Patients
By End User
· Hospitals
· Clinics
· Ambulatory Surgical Centers
· Optical Stores & Pharmacies
Regional Analysis
· North America: Leading market due to advanced ophthalmic infrastructure, high prevalence of eye disorders, and strong presence of key players.
· Europe: Growth driven by aging population, rising incidence of cataracts and glaucoma, and favorable reimbursement policies.
· Asia-Pacific: Fastest-growing region, supported by large patient base in China and India, increasing healthcare investments, and medical tourism.
· South America: Moderate growth, with Brazil and Argentina expanding ophthalmic care facilities.
· Middle East & Africa: Emerging market with growing investments in healthcare modernization and rising awareness of eye health.
Key Players
· Novartis AG
· Allergan Inc.
· Meda Pharmaceuticals Inc.
· Bausch & Lomb Inc.
· Cigna
· Similasan Corporation
· Visine
· Alcon Laboratories Inc.
· Viva Opti-Free
· Systane
· Rite Aid Corporation
· Walgreens Boots Alliance
· Clear Eyes
Additional Key Players:
· Johnson & Johnson Vision Care
· Bayer AG (ophthalmology division)
· Pfizer Inc. (ophthalmic products)
· Sun Pharmaceutical Industries Ltd.
· Cipla Ltd.
· Lupin Pharmaceuticals
· Teva Pharmaceutical Industries Ltd.
· Akorn Pharmaceuticals
Porter’s Five Forces Analysis
· Threat of New Entrants: Moderate; regulatory approvals and R&D costs limit entry.
· Bargaining Power of Suppliers: Moderate; specialized raw material suppliers hold leverage.
· Bargaining Power of Buyers: High; hospitals and clinics demand cost-effective and safe products.
· Threat of Substitutes: Low; mydriatic eyedrops are essential for diagnostic and surgical procedures.
· Industry Rivalry: High; competition among established pharmaceutical firms drives innovation.
SWOT Analysis
Strengths: Established clinical use, strong demand in ophthalmic diagnostics and surgeries, technological advancements. Weaknesses: High costs, limited access in developing regions. Opportunities: Pediatric ophthalmology, expansion in emerging markets, development of combination formulations. Threats: Regulatory hurdles, pricing pressures, competition from alternative diagnostic methods.
Trend Analysis
· Rising adoption of short-acting mydriatic eyedrops for outpatient diagnostics.
· Increasing use of combination formulations for enhanced efficacy.
· Growth in pediatric ophthalmology applications.
· Expansion of teleophthalmology and remote diagnostics.
· Integration of advanced drug delivery systems for improved patient comfort.
Drivers & Challenges
Drivers:
· Rising prevalence of eye disorders such as cataracts and glaucoma.
· Technological advancements in drug formulations.
· Growing demand for ophthalmic diagnostics and surgeries.
· Expanding healthcare infrastructure in emerging markets.
Challenges:
· High costs of advanced formulations.
· Limited reimbursement in some regions.
· Risk of side effects and complications.
· Shortage of trained ophthalmologists in developing countries.
Value Chain Analysis
· Raw Materials: Active pharmaceutical ingredients, excipients, packaging materials.
· Manufacturing: Drug formulation, sterilization, packaging.
· Distribution: Hospitals, clinics, pharmacies, optical stores.
· End Users: Patients undergoing diagnostics or ophthalmic surgeries.
· Aftermarket Services: Training, awareness programs, patient education.
Quick Recommendations for Stakeholders
· Manufacturers: Focus on cost-effective, short-acting, and pediatric-friendly formulations.
· Healthcare Providers: Adopt advanced mydriatic eyedrops for diagnostics and expand outpatient services.
· Regulators: Streamline approval processes while ensuring patient safety.
· Investors: Target companies innovating in ophthalmic drug delivery systems.
· Patients & Families: Benefit from safer, more comfortable, and accessible eye care solutions.
1. Market Overview of Mydriatic Eyedrops
1.1 Mydriatic Eyedrops Market Overview
1.1.1 Mydriatic Eyedrops Product Scope
1.1.2 Market Status and Outlook
1.2 Mydriatic Eyedrops Market Size by Regions:
1.3 Mydriatic Eyedrops Historic Market Size by Regions
1.4 Mydriatic Eyedrops Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Mydriatic Eyedrops Sales Market by Type
2.1 Global Mydriatic Eyedrops Historic Market Size by Type
2.2 Global Mydriatic Eyedrops Forecasted Market Size by Type
2.3 Atropine
2.4 Homatropine
2.5 Dolly
2.6 Others
3. Covid-19 Impact Mydriatic Eyedrops Sales Market by Application
3.1 Global Mydriatic Eyedrops Historic Market Size by Application
3.2 Global Mydriatic Eyedrops Forecasted Market Size by Application
3.3 Adult
3.4 Children
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Mydriatic Eyedrops Production Capacity Market Share by Manufacturers
4.2 Global Mydriatic Eyedrops Revenue Market Share by Manufacturers
4.3 Global Mydriatic Eyedrops Average Price by Manufacturers
5. Company Profiles and Key Figures in Mydriatic Eyedrops Business
5.1 Novartis AG
5.1.1 Novartis AG Company Profile
5.1.2 Novartis AG Mydriatic Eyedrops Product Specification
5.1.3 Novartis AG Mydriatic Eyedrops Production Capacity, Revenue, Price and Gross Margin
5.2 Allergan Inc.
5.2.1 Allergan Inc. Company Profile
5.2.2 Allergan Inc. Mydriatic Eyedrops Product Specification
5.2.3 Allergan Inc. Mydriatic Eyedrops Production Capacity, Revenue, Price and Gross Margin
5.3 Meda Pharmaceuticals Inc
5.3.1 Meda Pharmaceuticals Inc Company Profile
5.3.2 Meda Pharmaceuticals Inc Mydriatic Eyedrops Product Specification
5.3.3 Meda Pharmaceuticals Inc Mydriatic Eyedrops Production Capacity, Revenue, Price and Gross Margin
5.4 Bausch & Lomb Inc
5.4.1 Bausch & Lomb Inc Company Profile
5.4.2 Bausch & Lomb Inc Mydriatic Eyedrops Product Specification
5.4.3 Bausch & Lomb Inc Mydriatic Eyedrops Production Capacity, Revenue, Price and Gross Margin
5.5 Cigna
5.5.1 Cigna Company Profile
5.5.2 Cigna Mydriatic Eyedrops Product Specification
5.5.3 Cigna Mydriatic Eyedrops Production Capacity, Revenue, Price and Gross Margin
5.6 Similasan Corporation
5.6.1 Similasan Corporation Company Profile
5.6.2 Similasan Corporation Mydriatic Eyedrops Product Specification
5.6.3 Similasan Corporation Mydriatic Eyedrops Production Capacity, Revenue, Price and Gross Margin
5.7 Visine
5.7.1 Visine Company Profile
5.7.2 Visine Mydriatic Eyedrops Product Specification
5.7.3 Visine Mydriatic Eyedrops Production Capacity, Revenue, Price and Gross Margin
5.8 Alcon
5.8.1 Alcon Company Profile
5.8.2 Alcon Mydriatic Eyedrops Product Specification
5.8.3 Alcon Mydriatic Eyedrops Production Capacity, Revenue, Price and Gross Margin
5.9 Viva Opti-Free
5.9.1 Viva Opti-Free Company Profile
5.9.2 Viva Opti-Free Mydriatic Eyedrops Product Specification
5.9.3 Viva Opti-Free Mydriatic Eyedrops Production Capacity, Revenue, Price and Gross Margin
5.10 Bausch & Lomb
5.10.1 Bausch & Lomb Company Profile
5.10.2 Bausch & Lomb Mydriatic Eyedrops Product Specification
5.10.3 Bausch & Lomb Mydriatic Eyedrops Production Capacity, Revenue, Price and Gross Margin
5.11 Systane
5.11.1 Systane Company Profile
5.11.2 Systane Mydriatic Eyedrops Product Specification
5.11.3 Systane Mydriatic Eyedrops Production Capacity, Revenue, Price and Gross Margin
5.12 Rite Aid
5.12.1 Rite Aid Company Profile
5.12.2 Rite Aid Mydriatic Eyedrops Product Specification
5.12.3 Rite Aid Mydriatic Eyedrops Production Capacity, Revenue, Price and Gross Margin
5.13 Walgreens
5.13.1 Walgreens Company Profile
5.13.2 Walgreens Mydriatic Eyedrops Product Specification
5.13.3 Walgreens Mydriatic Eyedrops Production Capacity, Revenue, Price and Gross Margin
5.14 Staples
5.14.1 Staples Company Profile
5.14.2 Staples Mydriatic Eyedrops Product Specification
5.14.3 Staples Mydriatic Eyedrops Production Capacity, Revenue, Price and Gross Margin
5.15 Clear eyes
5.15.1 Clear eyes Company Profile
5.15.2 Clear eyes Mydriatic Eyedrops Product Specification
5.15.3 Clear eyes Mydriatic Eyedrops Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Mydriatic Eyedrops Market Size
6.2 North America Mydriatic Eyedrops Key Players in North America
6.3 North America Mydriatic Eyedrops Market Size by Type
6.4 North America Mydriatic Eyedrops Market Size by Application
7. East Asia
7.1 East Asia Mydriatic Eyedrops Market Size
7.2 East Asia Mydriatic Eyedrops Key Players in North America
7.3 East Asia Mydriatic Eyedrops Market Size by Type
7.4 East Asia Mydriatic Eyedrops Market Size by Application
8. Europe
8.1 Europe Mydriatic Eyedrops Market Size
8.2 Europe Mydriatic Eyedrops Key Players in North America
8.3 Europe Mydriatic Eyedrops Market Size by Type
8.4 Europe Mydriatic Eyedrops Market Size by Application
9. South Asia
9.1 South Asia Mydriatic Eyedrops Market Size
9.2 South Asia Mydriatic Eyedrops Key Players in North America
9.3 South Asia Mydriatic Eyedrops Market Size by Type
9.4 South Asia Mydriatic Eyedrops Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Mydriatic Eyedrops Market Size
10.2 Southeast Asia Mydriatic Eyedrops Key Players in North America
10.3 Southeast Asia Mydriatic Eyedrops Market Size by Type
10.4 Southeast Asia Mydriatic Eyedrops Market Size by Application
11. Middle East
11.1 Middle East Mydriatic Eyedrops Market Size
11.2 Middle East Mydriatic Eyedrops Key Players in North America
11.3 Middle East Mydriatic Eyedrops Market Size by Type
11.4 Middle East Mydriatic Eyedrops Market Size by Application
12. Africa
12.1 Africa Mydriatic Eyedrops Market Size
12.2 Africa Mydriatic Eyedrops Key Players in North America
12.3 Africa Mydriatic Eyedrops Market Size by Type
12.4 Africa Mydriatic Eyedrops Market Size by Application
13. Oceania
13.1 Oceania Mydriatic Eyedrops Market Size
13.2 Oceania Mydriatic Eyedrops Key Players in North America
13.3 Oceania Mydriatic Eyedrops Market Size by Type
13.4 Oceania Mydriatic Eyedrops Market Size by Application
14. South America
14.1 South America Mydriatic Eyedrops Market Size
14.2 South America Mydriatic Eyedrops Key Players in North America
14.3 South America Mydriatic Eyedrops Market Size by Type
14.4 South America Mydriatic Eyedrops Market Size by Application
15. Rest of the World
15.1 Rest of the World Mydriatic Eyedrops Market Size
15.2 Rest of the World Mydriatic Eyedrops Key Players in North America
15.3 Rest of the World Mydriatic Eyedrops Market Size by Type
15.4 Rest of the World Mydriatic Eyedrops Market Size by Application
16 Mydriatic Eyedrops Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Market Segmentation
By Type
· Atropine Eyedrops
· Homatropine Eyedrops
· Tropicamide Eyedrops
· Cyclopentolate Eyedrops
· Dolly Eyedrops
· Others (combination formulations, customized solutions)
By Application
· Adults
· Children
· Geriatric Patients
By End User
· Hospitals
· Clinics
· Ambulatory Surgical Centers
· Optical Stores & Pharmacies
Regional Analysis
· North America: Leading market due to advanced ophthalmic infrastructure, high prevalence of eye disorders, and strong presence of key players.
· Europe: Growth driven by aging population, rising incidence of cataracts and glaucoma, and favorable reimbursement policies.
· Asia-Pacific: Fastest-growing region, supported by large patient base in China and India, increasing healthcare investments, and medical tourism.
· South America: Moderate growth, with Brazil and Argentina expanding ophthalmic care facilities.
· Middle East & Africa: Emerging market with growing investments in healthcare modernization and rising awareness of eye health.
Key Players
· Novartis AG
· Allergan Inc.
· Meda Pharmaceuticals Inc.
· Bausch & Lomb Inc.
· Cigna
· Similasan Corporation
· Visine
· Alcon Laboratories Inc.
· Viva Opti-Free
· Systane
· Rite Aid Corporation
· Walgreens Boots Alliance
· Clear Eyes
